The use of medications for inflammatory bowel disease during pregnancy and nursing

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.11, 2005-09, pp. : 1833-1839

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treating Inflammatory Bowel Disease During Pregnancy: Risks and Safety of Drug Therapy

By Connell W. Miller A.

Drug Safety, Vol. 21, Iss. 4, 1999-10 ,pp. : 311-323

Adis International

Access to resources Recommend Favorite

Predictors of the use of medications before and during pregnancy

By Odalovic Marina

International Journal of Clinical Pharmacy, Vol. 35, Iss. 3, 2013-06 ,pp. : 408-416

Springer Publishing Company

Access to resources Recommend Favorite

Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease

By Saha Sumona Wald Arnold

Expert Opinion on Drug Safety, Vol. 11, Iss. 6, 2012-11 ,pp. : 947-957

Informa Healthcare

Access to resources Recommend Favorite

Anti-TNF Antibody Therapy for Inflammatory Bowel Disease During Pregnancy: A Clinical Review

Current Drug Targets, Vol. 11, Iss. 2, 2010-02 ,pp. : 234-241

Bentham Science Publishers

Access to resources Recommend Favorite

The use of tacrolimus in the treatment of inflammatory bowel disease

By Chow Dorothy KL Leong Rupert WL

Expert Opinion on Drug Safety, Vol. 6, Iss. 5, 2007-09 ,pp. : 479-485

Informa Healthcare

Access to resources Recommend Favorite